Provided by Tiger Fintech (Singapore) Pte. Ltd.

Annexon, Inc.

2.59
-0.0100-0.38%
Post-market: 2.42-0.1731-6.68%18:47 EDT
Volume:925.66K
Turnover:2.37M
Market Cap:284.16M
PE:-2.22
High:2.66
Open:2.64
Low:2.49
Close:2.60
Loading ...

Annexon Biosciences Holds Annual Stockholders Meeting

TIPRANKS
·
9 hours ago

Annexon Inc. Concluded Annual Stockholders Meeting

Reuters
·
10 hours ago

Annexon Inc. Announces CEO Douglas Love to Present at Jefferies Global Healthcare Conference

Reuters
·
30 May

Annexon presents tanruprubart data at PNS annual meeting

TIPRANKS
·
20 May

BRIEF-Annexon Reports Inducement Grants To New Employees Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
17 May

Annexon Inc. Announces Inducement Grants for New Employees Under 2022 Employment Inducement Award Plan

Reuters
·
17 May

Annexon price target lowered to $14 from $20 at H.C. Wainwright

TIPRANKS
·
13 May

Annexon Is Maintained at Buy by Needham

Dow Jones
·
13 May

Annexon Biosciences Reports Increased Q1 2025 Losses

TIPRANKS
·
13 May

TD Cowen Sticks to Its Buy Rating for Annexon Biosciences (ANNX)

TIPRANKS
·
13 May

Annexon Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
12 May

Annexon Q1 EPS $(0.37) Misses $(0.29) Estimate

Benzinga
·
12 May

Annexon Inc expected to post a loss of 30 cents a share - Earnings Preview

Reuters
·
10 May

Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
17 Apr

Annexon Biosciences’ ANX005: Promising Phase III Results and Strategic Initiatives Drive Buy Rating

TIPRANKS
·
10 Apr

Annexon's Investigational Drug Shows Rapid Recovery And Durable Benefit In Rare Neurological Disorder

Benzinga
·
10 Apr

Annexon Cites 'Durable Benefit' of Tanruprubart in Guillain-Barre Syndrome Trial

MT Newswires Live
·
09 Apr

Annexon Highlights Pivotal Data on First Potential Targeted Therapy for Guillain-Barré Syndrome (GBS) and Showcases New GBS Education Campaign at American Academy of Neurology (AAN) 2025 Annual Meeting

GlobeNewswire
·
09 Apr

Annexon Highlights Leadership in Advancing Clinical Research and Education for Guillain-Barré Syndrome (GBS) at American Academy of Neurology (AAN) 2025 Annual Meeting

GlobeNewswire
·
04 Apr

Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
18 Mar